Using tests and models to assess antidepressant-like activity in rodents

1. Abelaira H.M., Réus G.Z., Quevedo J.: Animal models as tools to study the pathophysiology of depression. Revista Brasileira de Psiquiatria, 35, 201310.1590/1516-4446-2013-1098Search in Google Scholar

2. Avgustinovich D.F., Kovalenko I.L., Kudryavtseva N.N.: A model of anxious depression: persistence of behavioral pathology. Neuroscience and Behavioral Physiology, 35, 917–924, 200510.1007/s11055-005-0146-6Search in Google Scholar

3. Berton O. et al.: Essential role of BDNF in mesolimbic dopamine pathway in social defeat stress. Science, 311, 864-868, 200610.1126/science.1120972Search in Google Scholar

4. Brown G.W., Prudo R.: Psychiatric disorder in a rural and an urban population: Ethology of depression. Psychological Medicine, 11, 581-599, 198110.1017/S0033291700052880Search in Google Scholar

5. Coppen A.: The biochemistry of affective disorder. British Journal of Psychiatry, 7, 113, 1237-1264, 196710.1192/bjp.113.504.1237Search in Google Scholar

6. Costa E., Garattini S., Valzelli L.: Interactions between reserpine, chlorpromazine and imipramine. Experientia, 16, 461-463, 196010.1007/BF02171155Search in Google Scholar

7. Dall’olio R. et al.: Behavioral differentiation between pharmacokinetic and pharmacodynamics components of the interaction of antidepressants or neuroleptics with methamphetamine. Psychopharmacology, 90, 18-23, 198610.1007/BF00172865Search in Google Scholar

8. Everett G.M.: The DOPA response potentiation test and its use in screening for antidepressant drugs. Excerpta Medica, 6, 164-167, 1971Search in Google Scholar

9. Fava M., Kendler K.S.: Major depressive disorder. Neuron, 28, 335-341, 200010.1016/S0896-6273(00)00112-4Search in Google Scholar

10. Halliwell G., Qunton R.M., Williams F.E.: A comparison of imipramine, chloropromazine and related drugs in various test involving autonomic functions and antagonism of reserpine. Br. J. Pharmacol., 23, 330-350, 196410.1111/j.1476-5381.1964.tb01590.x170409614228134Search in Google Scholar

11. Holsboer F.: Antidepressant drug discovery in the postgenomic era. World J. Biol. Psychiatry, 2, 165–177, 200110.3109/1562297010902680512587145Search in Google Scholar

12. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 23, 477–501, 200110.1016/S0893-133X(00)00159-7Search in Google Scholar

13. Hua-Cheng YAN et al.: Behavioral animal models of depression. Neuroscience Bulletin, 26, 327-337, 201010.1007/s12264-010-0323-7Search in Google Scholar

14. Huhman K.L.: Social conflict models: Can they inform us about human psychopathology? Horm. Behav., 50, 640-646, 200610.1016/j.yhbeh.2006.06.022Search in Google Scholar

15. Katz R.J., Roth K.A., Carroll B.J.: Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neuroscience and Biobehavioral Reviews, 5, 247-251, 198110.1016/0149-7634(81)90005-1Search in Google Scholar

16. Krishnan V. et al.: Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell, 131, 391-404, 200710.1016/j.cell.2007.09.018Search in Google Scholar

17. Kudryavtseva N.N., Bakshtanovskaya I.V., Koryakina L.A.: Social model of depression in mice of C57BL/6J strain. Pharmacol. Biochem. Behav., 38, 315-320, 199110.1016/0091-3057(91)90284-9Search in Google Scholar

18. Lazure K. et al.: Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial. Head Neck-Journal for Sciences Specialties Head Neck, 31, 888-892, 200910.1002/hed.21046Search in Google Scholar

19. Litwack G. (2010). Models of depression. In: Hormones of the limbic system. Duman C.H., p.1-15Search in Google Scholar

20. McKenna M.T et al.: Assessing the burden of disease in the United States using disability-adjusted life years. Journal of Preventive Medicine, 28, 415-423, 200510.1016/j.amepre.2005.02.009Search in Google Scholar

21. Musselman D.L., Evans D.L., Nemeroff C.B.: The relationship of depression to cardiovascular disease, epidemiology, biology, and treatment. Archives of General Psychiatry, 55, 580-592, 199810.1001/archpsyc.55.7.580Search in Google Scholar

22. Nestler J. E. et al.: Neurobiology of depression. Neuron, 34, 13-35, 200210.1016/S0896-6273(02)00653-0Search in Google Scholar

23. Neu P.: Correlation of depression with stroke. Pathophysiological mechanisms. Nervenarzt, 80, 772, 200910.1007/s00115-009-2720-6Search in Google Scholar

24. Papp M., Moryl E., Wilner P.: Pharmacological validation of the chronic mild stress model of depression. Eur. J. Pharmacol., 296, 129-136, 199610.1016/0014-2999(95)00697-4Search in Google Scholar

25. Páez-Pereda M.: New drug targets in the signalling pathways activated by antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29, 1010-1016, 200510.1016/j.pnpbp.2005.03.017Search in Google Scholar

26. Petit-Demouliere B., Chenu F., Bourin M.: Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology, 177, 245-255, 200510.1007/s00213-004-2048-7Search in Google Scholar

27. Peyrot, M.: Depression: a quiet killer by any name. Diabetes Care, 26, 2952-2953, 200310.2337/diacare.26.10.2952Search in Google Scholar

28. Popik P.: Metodyka przedklinicznych badań nad depresją i lekami przeciwdepresyjnymi. Depresja i leki przeciwdepresyjne – 10 lat później. Przewłocka B (red.), XIII Zimowa Szkoła Instytutu Farmakologii PAN, 27-44, 1996Search in Google Scholar

29. Porsolt R.D. et al.: Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol., 47, 379-91, 197810.1016/0014-2999(78)90118-8Search in Google Scholar

30. Porsolt R.D., Bertin A., Jalfre M.: Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther., 36, 229-327, 1977Search in Google Scholar

31. Porsol R.D., Bertin A. Jalfre M.: Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther., 229(2), 327–336, 1977Search in Google Scholar

32. Porsolt R.D. Le Pichon M. Jalfre M.: Depression: A new animal model sensitive to antidepressant treatments. Nature, 266(5604), 730–732, 197710.1038/266730a0Search in Google Scholar

33. Porsolt R.D., Bertin A. Jalfre M.:‘‘Behavioural despair’’ in rats and mice: Strain differences and the effects of imipramine. Eur. J. Pharmacol., 51(3), 291–294, 197810.1016/0014-2999(78)90414-4Search in Google Scholar

34. Pothion S. et al.: Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav. Brain. Res., 155, 135-146, 200410.1016/j.bbr.2004.04.00815325787Search in Google Scholar

35. Sapolsky R.M.: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry, 57, 925–935, 200010.1001/archpsyc.57.10.92511015810Search in Google Scholar

36. Schildkraut J.J.: The catecholamine hypothesis of affective disorder: a review of supporting evidence. American Journal of Psychiatry, 122, 1032-1039, 196510.1176/ajp.122.5.5095319766Search in Google Scholar

37. Seligman M.E.P., Maier S.F., Peterson Ch. (1995), Learned Helplessness. A Theory for the Age of Personal Control.Search in Google Scholar

38. Stemmelin J, et al.: Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress. Behav. Brain Res., 206, 310-312, 201010.1016/j.bbr.2009.09.00319744528Search in Google Scholar

39. Steru L. et al.: Tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology, 85, 367–370, 198510.1007/BF004282033923523Search in Google Scholar

40. Vaishnav K., Nestler E. J. (2013). Animal Models of Depression: Molecular Perspectives. In: Molecular and Functional Models in Neuropsychiatry. Hagan J. J. (editor) p.121-148Search in Google Scholar

41. Willner P. (1991). Behavioural models in psychofarmacology. Theoretical, industrial and clinical perspectives. p.91-113Search in Google Scholar

42. Willner P., Mitchell P.J.: The validity of animal models of predisposition to depression. Behav Pharmacol., 13, 169-188, 200210.1097/00008877-200205000-0000112122308Search in Google Scholar